CONNECTED HEALTH CONFERENCE • SAVE THE DATE • October 16-18, 2019 • Boston, MA
The session will look at how Teva is pioneering digital respiratory solutions, which look to address the inherent patient un-met needs of adequate control as a result of technique and adherence challenges. The approach started off with a premise: looking to reengineer the inhaler, which has remained relatively untouched for over 60 years.
The result…ProAir® Digihaler™, the first and only digital inhaler with built-in sensors that detect when the inhaler is used and measure inspiratory flow.
During this session Teva will share a little about current thinking and what guides future plans.